Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killer cells
about
Structure, evolution, and biology of the MUC4 mucinMucins in cancer: function, prognosis and therapyThe membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cellsT Lymphocyte-Endothelial Interactions: Emerging Understanding of Trafficking and Antigen-Specific ImmunityClinicopathological and prognostic significance of MUC4 expression in cancers: evidence from meta-analysisMucins in neoplasms of pancreas, ampulla of Vater and biliary systemThe membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanismsSynthesis and secretion of Muc4/sialomucin complex: implication of intracellular proteolysisMucin 21/epiglycanin modulates cell adhesionMucins in ovarian cancer diagnosis and therapyMUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cellsMuc4/MUC4 functions and regulation in cancerMUC16 (CA125): tumor biomarker to cancer therapy, a work in progressExpression of Mucin 4 in leukoplakia and oral squamous cell carcinoma: An immunohistochemical study.MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progeniesSteric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein.Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.The immunomodulating roles of glycoproteins in epithelial ovarian cancer.MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas.Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.Role of mucins in the skin during benign and malignant conditions.Transmembrane mucins as novel therapeutic targetsAntigen recognition is facilitated by invadosome-like protrusions formed by memory/effector T cells.Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy.Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis.Resistance to trastuzumab in HER2-positive mucinous invasive ductal breast carcinoma.MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells.TGFbeta regulation of membrane mucin Muc4 via proteosome degradation.Mucins in pancreatic cancer and its microenvironment.MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma.MUC4 is increased in high grade intraepithelial neoplasia in Barrett's oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio.Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.Molecular Pathways: Mucins and Drug Delivery in Cancer.
P2860
Q24630985-794C5351-6AD7-4ABF-980F-41F63BFE532AQ24633765-2080AF0A-8CFB-470B-BD49-17F7C16D5714Q24644445-6DF57DB0-33F5-4C7A-9780-1AAB92089996Q26774645-1C4B54AD-8A6B-4F1A-9919-8D1F25E4A36BQ26784326-7ADE9463-9580-4D82-9D81-21B0E0F8AECAQ28070355-618F836A-3CF9-44C9-B084-4BF52DD03114Q28566287-4BB22ED8-1EB5-4FA2-B69F-FE807FB7E22DQ28575052-65190D15-2BCA-4469-AE9B-D89D7F0D21C0Q28591214-302849E1-4585-42EC-9C38-5D10CFE504D6Q33583166-8180F7C7-FD15-410A-9CD0-2B6EB90B30EFQ33638962-03EDD17A-55FF-453A-AC9B-C8E4F0C2104AQ33674729-D561BCBA-F04F-4636-AA19-8163DAC27EE3Q33713506-BCACDEA6-F9D4-4C7A-98B6-80B226FDCC0DQ33785772-D8C6F862-8F98-4DBD-9660-6E0C7C6609E0Q33938044-B19063FC-CB29-41EF-BC9D-5227F3DDBC5EQ34115190-E4639D0D-622C-4D1E-AFBC-5C86BAD8940BQ34698008-14336C2E-E17C-463F-B23E-A0B3F74C2DE5Q34988382-E667A433-51AF-4BD0-ABA8-1C8CBED2FCA2Q35077893-BE19DCB8-8E3B-43ED-88B1-178F2D7CBEFEQ35589094-C459AB73-C5EF-4EA7-8FB8-546EEFD41856Q35591546-1389650B-CBC4-44BC-A1AA-C0FE2870FBBEQ35596376-9746CE46-D151-4454-8BC2-E4182BE7B43BQ35632645-9404103F-D53B-4695-AAA6-9CF8F707C47CQ35884077-89638BF8-5271-4A63-BD21-14BFE9DE83ABQ35923257-EAEFF57A-77C2-43D8-9CC5-7A2B154AB44BQ36053164-E9896F86-1281-4DF8-9BDF-FDA6E6345898Q36751896-64D29182-7C9D-4221-A530-A5E0399287FEQ36858047-F2535313-2AE0-48A9-8A24-424AABD40F73Q37349929-F0DD8BDE-97C7-46D2-AF57-7A8AE663BB32Q38121746-5BE11D93-4AB5-4E21-888B-0E4FE82FC5A8Q38688917-4A46A5AD-73F1-4891-9459-C1BC5852C985Q43010427-E28059F8-4085-4F0E-BF3F-DC8C87D78FD3Q46214152-6B88C98A-9408-4635-98A6-AD0F9018FED8Q50465411-BD70AB63-3166-469E-837D-96ECC342C357
P2860
Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killer cells
description
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1999
@ast
im Mai 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1999/05/01)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/05/01)
@nl
наукова стаття, опублікована в травні 1999
@uk
مقالة علمية (نشرت في مايو 1999)
@ar
name
Overexpression of sialomucin c ...... phokine-activated killer cells
@ast
Overexpression of sialomucin c ...... phokine-activated killer cells
@en
Overexpression of sialomucin c ...... phokine-activated killer cells
@nl
type
label
Overexpression of sialomucin c ...... phokine-activated killer cells
@ast
Overexpression of sialomucin c ...... phokine-activated killer cells
@en
Overexpression of sialomucin c ...... phokine-activated killer cells
@nl
prefLabel
Overexpression of sialomucin c ...... phokine-activated killer cells
@ast
Overexpression of sialomucin c ...... phokine-activated killer cells
@en
Overexpression of sialomucin c ...... phokine-activated killer cells
@nl
P2093
P3181
P1433
P1476
Overexpression of sialomucin c ...... phokine-activated killer cells
@en
P2093
P304
P3181
P407
P577
1999-05-01T00:00:00Z